|
NEURONTIN SUICIDE
Neurontin has been linked to suicidal behavior and death. Pfizer plead guilty in 2004 to accusations of unlawfully promoting Neurontin for unapproved uses.
Neurontin (generic name: gabapentin) has been approved by the FDA and prescribed by millions of physicians for two different ailments: controlling seizures and reducing pain caused by shingles. While the FDA and the drug company continue to receive reports of suicidal behaviours on patients taking Neurontin, Pfizer continues to promote the dangerous drug which brought in over $2 billion in 2004.
Neurontin was approved in 1993 by the FDA for use as an anti-convulsant for people suffering from partial seizures associated with epilepsy. This treatment is currently prescribed for children and adults suffering from simple and complex seizures.
Neurontin has also been FDA-approved for the management of post-herpetic neuralgia (PHN). PHN is common for those with herpes or shingles, typically those over 60 years of age.
Neurontin side effects include:
suicidal behavior/attempted suicide, paranoia, memory loss, hostility, unsteadiness, severe mania, depression, abnormal thinking, lack of coordination, dizziness, drowsiness, water retention, nausea and/or vomiting, ataxia (inability to control muscles), fatigue, and/or viral infection.
In 2004, Pfizer, the manufacturer of Neurontin, pleaded guilty to charges of unlawful activity by Warner-Lambert in the promotion and marketing of Neurontin for unapproved uses and agreed to a $430 million settlement. Before this settlement, thousands of patients were prescribed Neurontin for non-approved uses such as:
• bipolar disorder;
• pain syndromes, peripheral neuropathy, diabetic neuropathy;
• treatment of epilepsy alone (monotherapy);
• reflex sympathetic dystrophy (RSD);
• attention deficit disorder (ADD);
• restless leg syndrome (RLS);
• trigeminal neuralgia;
• essential tremor;
• migraines;
• chronic pain; and
• drug and alcohol withdrawal seizures.
|
 |
|